Status:

UNKNOWN

Prehospital Kcentra for Hemorrhagic Shock

Lead Sponsor:

Oregon Health and Science University

Conditions:

Trauma Injury

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This is a pilot trial being performed to evaluate the feasibility, to include the ability of EMS to identify patients in shock and the ability to package, store, and administer Kcentra in the field.

Detailed Description

Prospective randomized trials have shown that 4-factor prothrombin complex concentrate (4FPCCs) result in more rapid correction of coagulopathy and greater likelihood of achieving hemostasis in patien...

Eligibility Criteria

Inclusion

  • Trauma patients age 18 years or greater, or weight \> 50 kg if age unknown
  • Systolic blood pressure \< 70 mmHg
  • Suspicion of hemorrhagic shock based on mechanism of injury
  • EMS transport to a participating trauma center

Exclusion

  • Age less than 18
  • Unknown time of injury
  • Out-of-hospital cardiopulmonary resuscitation
  • Known history of thromboembolic disorders or stroke or suspicion by EMS of a recent stroke
  • Known oral anti-coagulant use to include warfarin and novel anti-coagulants
  • Severe hypothermia (\<28°C)
  • Drowning or asphyxia due to hanging
  • Burns more than 20% total body surface area
  • Evidence of devastating blunt traumatic brain injury to include fixed and dilated pupils, asymmetric pupils and extrusion of brain matter
  • Isolated blunt or penetrating head injury
  • Isolated spinal cord injury
  • Ground level (same level) falls
  • Inability to obtain intravenous access
  • Inability to administer randomized therapy within 4 hours of ambulance notification
  • Known transfers and inter-facility transfers
  • Known Do Not Resuscitate (DNR) prior to randomization
  • Known or suspected pregnancy
  • Known prisoners
  • Patients who have activated the "opt-out" process

Key Trial Info

Start Date :

March 15 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 31 2025

Estimated Enrollment :

166 Patients enrolled

Trial Details

Trial ID

NCT04019015

Start Date

March 15 2021

End Date

March 31 2025

Last Update

December 15 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Oregon Health & Science University

Portland, Oregon, United States, 97239